Relebactam
Back to searchMolecule Structure
Scientific Name
Relebactam
Description of the Drug
Relebactam is a beta-lactamase inhibitor used to prevent hydrolysis of beta-lactam antibiotics, leading to increased effectiveness.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12377
http://www.drugbank.ca/drugs/DB12377
Brand Name(s)
Not Available
Company Owner(s)
Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbapenem-hydrolyzing beta-lactamase KPC | SINGLE PROTEIN | INHIBITOR | CHEMBL3562180 |
| Beta-lactamase CTX-M | SINGLE PROTEIN | INHIBITOR | CHEMBL6131 |
| Beta-lactamase | SINGLE PROTEIN | INHIBITOR | CHEMBL5031 |
| Beta-lactamase SHV-1 | SINGLE PROTEIN | INHIBITOR | CHEMBL5094 |
| Bacterial beta-lactamase TEM | SINGLE PROTEIN | INHIBITOR | CHEMBL2364670 |
| Beta-lactamase | SINGLE PROTEIN | INHIBITOR | CHEMBL2725 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL17709595 | SCHEMBL3721178 | |
| DrugBank | DB12377 | ||
| PubChem: Thomson Pharma | 84982177 | ||
| PubChem | 44129647 | 121301826 | |
| Nikkaji | J3.628.086G | ||
| BindingDB | 1858 | 50447651 | |
| DrugCentral | 5342 | ||
| Brenda | 206586 | ||
| Guide to Pharmacology | 10852 | ||
| rxnorm | RELEBACTAM ANHYDROUS | RELEBACTAM MONOHYDRATE | RELEBACTAM |
| PubChem: Drugs of the Future | 123055439 | ||
| ZINC | ZINC000043206319 |
